Related references
Note: Only part of the references are listed.Oral Pathology in Portuguese Dogs: An Eight-Year Biopsy-Based Retrospective Study
Leonor Delgado et al.
JOURNAL OF VETERINARY DENTISTRY (2023)
Critical pathways of oral squamous cell carcinoma: molecular biomarker and therapeutic intervention
Sharmistha Dey et al.
MEDICAL ONCOLOGY (2022)
Risk Reversal of Oral, Pharyngeal and Oesophageal Cancers after Cessation of Betel Quid Users: A Systematic Review and Meta-Analysis
Ruchika Gupta et al.
ANNALS OF GLOBAL HEALTH (2022)
Secondhand smoke exposure and oral cancer risk: a systematic review and meta-analysis
Lorena C. Mariano et al.
TOBACCO CONTROL (2022)
mTOR Inhibition Ablates Cisplatin-Resistant Salivary Gland Cancer Stem Cells
T. Nakano et al.
JOURNAL OF DENTAL RESEARCH (2021)
Treatment of canine oral papillary squamous cell carcinoma using definitive-intent radiation as a monotherapy-a case series
Francine van der Steen et al.
VETERINARY AND COMPARATIVE ONCOLOGY (2021)
Worldwide prevalence of PI3K-AKT-mTOR pathway mutations in head and neck cancer: A systematic review and meta-analysis
Adriana Castelo de Moura et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Oral Cancer Screening: Past, Present, and Future
S. Warnakulasuriya et al.
JOURNAL OF DENTAL RESEARCH (2021)
Inhibition of mTOR signaling and clinical activity of metformin in oral premalignant lesions
J. Silvio Gutkind et al.
JCI INSIGHT (2021)
PI3K/AKT/mTOR signaling as a molecular target in head and neck cancer
Franziska E. Marquard et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Global patterns and trends in cancers of the lip, tongue and mouth
Adalberto Miranda-Filho et al.
ORAL ONCOLOGY (2020)
Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
Choudhary Harsha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Radiosensitising Cancer Using Phosphatidylinositol-3-Kinase (PI3K), Protein Kinase B (AKT) or Mammalian Target of Rapamycin (mTOR) Inhibitors
Kasun Wanigasooriya et al.
CANCERS (2020)
Curcumin downregulates thePI3K-AKT-mTORpathway and inhibits growth and progression in head and neck cancer cells
Gabriel Alvares Borges et al.
PHYTOTHERAPY RESEARCH (2020)
PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond
Sadegh Fattahi et al.
LIFE SCIENCES (2020)
mTOR inhibitor use in head and neck squamous cell carcinoma: A meta-analysis on survival, tumor response, and toxicity
Jaimin Patel et al.
LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2020)
p-mTOR, p-4EBP-1 and eIF4E expression in canine prostatic carcinoma
Luis G. Rivera-Calderon et al.
RESEARCH IN VETERINARY SCIENCE (2019)
Immunohistochemical expression of selected phosphoproteins of the mTOR signalling pathway in canine cutaneous squamous cell carcinoma
B. L. Sanz Ressel et al.
VETERINARY JOURNAL (2019)
Simultaneous activation of impaired autophagy and the mammalian target of rapamycin pathway in oral squamous cell carcinoma
Xubin Yin et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2019)
Targeted disruption of PI3K/Akt/mTOR signaling pathway, via PI3K inhibitors, promotes growth inhibitory effects in oral cancer cells
Sadhna Aggarwal et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
Immunohistochemical Characterization of Canine Oral Papillary Squamous Cell Carcinoma
Tuddow Thaiwong et al.
VETERINARY PATHOLOGY (2018)
mTOR Pathway in Papillary Thyroid Carcinoma: Different Contributions of mTORC1 and mTORC2 Complexes for Tumor Behavior and SLC5A5 mRNA Expression
Catarina Tavares et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Outcomes following surgical excision or surgical excision combined with adjunctive, hypofractionated radiotherapy in dogs with oral squamous cell carcinoma or fibrosarcoma
Julia Riggs et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2018)
NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect
Cheng-Ming Hsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Phosphorylated ribosomal protein S6 correlation with p21 expression and inverse association with tumor size in oral squamous cell carcinoma
Juan C. de Vicente et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2017)
mTOR co-targeting strategies for head and neck cancer therapy
Zhiyong Wang et al.
CANCER AND METASTASIS REVIEWS (2017)
mTOR pathway protein immunoexpression as a prognostic factor for survival in head and neck cancer patients: a systematic review and meta-analysis
Ana Elizia Mascarenhas Marques et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2016)
Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
Naoya Maekawa et al.
PLOS ONE (2016)
Activation of Mammalian Target of Rapamycin in Canine Mammary Carcinomas: An Immunohistochemical Study
L. Delgado et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2015)
The therapeutic effects of SET/I2PP2A inhibitors on canine melanoma
Shuhei Enjoji et al.
JOURNAL OF VETERINARY MEDICAL SCIENCE (2015)
Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
Daniel R. Simpson et al.
ORAL ONCOLOGY (2015)
Human Genetic Relevance and Potent Antitumor Activity of Heat Shock Protein 90 Inhibition in Canine Lung Adenocarcinoma Cell Lines
Francisco Clemente-Vicario et al.
PLOS ONE (2015)
Risk factors associated with survival in dogs with nontonsillar oral squamous cell carcinoma: 31 cases (1990-2010)
Amy J. Fulton et al.
JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION (2013)
Phosphorylated mammalian target of rapamycin is associated with an adverse outcome in oral squamous cell carcinoma
Luis Silva Monteiro et al.
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY (2013)
Clinical, Histologic, and Computed Tomographic Features of Oral Papillary Squamous Cell Carcinoma in Dogs: 9 cases (2008-2011)
Jason W. Soukup et al.
JOURNAL OF VETERINARY DENTISTRY (2013)
The class I PI3K/Akt pathway is critical for cancer cell survival in dogs and offers an opportunity for therapeutic intervention
Yu-Ting Chen et al.
BMC VETERINARY RESEARCH (2012)
The mTOR Signalling Pathway in Human Cancer
Helena Populo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Immunohistochemical Analysis of the Akt/mTOR/4E-BP1 Signalling Pathway in Canine Haemangiomas and Haemangiosarcomas
A. Murai et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2012)
Histological Subtypes of Oral Non-tonsillar Squamous Cell Carcinoma in Dogs
A. Nemec et al.
JOURNAL OF COMPARATIVE PATHOLOGY (2012)
Rapamycin Pharmacokinetic and Pharmacodynamic Relationships in Osteosarcoma: A Comparative Oncology Study in Dogs
Melissa C. Paoloni et al.
PLOS ONE (2010)
Activation of the AKT and mammalian target of rapamycin pathways and the inhibitory effects of rapamycin on those pathways in canine malignant melanoma cell lines
Michael S. Kent et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2009)
Causes of oral cancer - an appraisal of controversies
S. Warnakulasuriya
BRITISH DENTAL JOURNAL (2009)
A review of human carcinogens-Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish
Beatrice Secretan et al.
LANCET ONCOLOGY (2009)
Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs
Ira K. Gordon et al.
AMERICAN JOURNAL OF VETERINARY RESEARCH (2008)
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck
P Amornphimoltham et al.
CANCER RESEARCH (2005)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Share Paper
